Severe immune thrombocytopenia in a critically ill COVID-19 patient

The novel coronavirus SARS-CoV-2 can cause a severe and even fatal respiratory illness named COVID-19. Apart from respiratory failure, COVID-19 may be associated with various autoimmune complications. We present a case of a critically ill patient with COVID-19 who developed severe immune thrombocytopenia that was successfully treated with a concomitant use of corticosteroids and intravenous immunoglobulins..

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:99

Enthalten in:

International Journal of Infectious Diseases - 99(2020), Seite 269-271

Sprache:

Englisch

Beteiligte Personen:

Ziga Martincic [VerfasserIn]
Barbara Skopec [VerfasserIn]
Karla Rener [VerfasserIn]
Matej Mavric [VerfasserIn]
Tomaz Vovko [VerfasserIn]
Matjaz Jereb [VerfasserIn]
Milica Lukic [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.sciencedirect.com [kostenfrei]
Journal toc [kostenfrei]

Themen:

COVID-19
Corticosteroids
Immune thrombocytopenia
Infectious and parasitic diseases
Intravenous immunoglobulins
SARS-CoV-2

doi:

10.1016/j.ijid.2020.08.002

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ036295647